Introduction
Acute ution involves a myriad of cellular and humoral mechanisms which produce rapidly developing increases in vascular permeability, changes in bl& BOW, and the mobilization, accumulation and activation of leukocytes, mainly neutrophils and monocytes. Recent work has ill uminaWl several important aspect5 of the acute inflammatory response which will be discussed here: (1) adhesive interactions between leukocytes and vascular endothelial cells; (2) leukocyte penetration of the bloed vessel wall; (3) leukocyte chemotaxis; (4) mechanisms of tissue injury, and (5) the overall biological role of cytokines in inducing some of these responses.
Adhesive interactions between neutrophils and endothelial cells
Neutrophil adhesion to the blood vessel wall is an early event in the infkunmatory response and is necessary for leukocyte accumulation within the inflammatoty site. 0.n the basis of in vitro studies, several mechanisms that could be responsible for mediating this critical interaction between neutrophils and blood vessel endothelial cells have been described (Fig. 1 ).
Critical to understanding neutrophil-endothelial cell adhesive mechanisms in Mlammation is the idea that the speciíìcity of the reaction in vivo seems to reside in an altered endothelium. That is, neutrophils appear to adhere only to modifìed endothelium, rather than at random, as would be expected if neutrophil activation were the initiator of adhesion. Recognition of this can be found insome of the earliest studies in experimental pathology (Cohnheim, Lectures on General Pathology, New Sydenham Society, 1889). Studies elucidating some of these changes in the endothelium have resulted in new insights into adhesive interactions.
ElAh4-1
The best understood mechanism of endothelial-based neutrophil-endothelial cell adhesion results from the synthesis of endothelial leukocyte adhesion molecule (ELAM)-1 by endothelial cells and its expression at their apical surface after activation of the endothelium by cytokines. ELAM-1 was identified using a panel of monoclonal antibodies raised against cytokine-treated endothelial cells. These were screened for their ability to bind selectively to activa&d endothelial cells and to inhibit neutrophil adhesion to cytokine-activa& endothelial cells (Bevilacqua et aC, Proc NatlA& Sci USA 1987, 84:923%9242). Use of the antibodies led to the defìnition of a molecule that could be immunoprecipitated from activa&d endothelial cells and the cloning of ELAM-1 from an endothelial complementary DNA (cDNA) library expressed in COS cells [ll. A single transcript of 3.9 kb appears to result in the translation of two peptides of similar molecular weight, probably Mering only in post-transla tional modiíìcations. The EIAM-1 molecule known to induce neutrophil adhesion on its own, as COS cells transfected with EIAM-1 are capable of binding neutrophils.
The kinetics of transcription of ELAM-1 messenger RNA (mRNA), followed using the cloned cDNA, the appearante of protein in the endothelial cytoplasmic membrane detected with an antibody to ELAM1, and the induction of neutrophil adhesiveness following cytokine stimulation, are all consistent and show a significant induction at 0.5 h, with activity peaking at 4-6 h and waning over 24 h. This also closely follows the kinetics of neutrophil accumulation in vivoafter cytokine administration and in inflammatory responses generally. ELAIv-1 is induced on endothelial cells after treatment with the cytokines tumor necrosis factor (TNF)u, lymphotoxin (TNFB), and interleukin (IL)-lp, and also after endothelial cells have contacted bacterial endotoxin (Bevilacqua et al, Proc Natl Acad Sci USA 1987, 84:9238-9242 The nucleotide sequence of ELAM-1 has revealed intriguing relationships with other classes of proteins, including the lymphocyte homing receptor recognized by the MEL-14 antibody, the platelet and endothelial cell activation molecule, granule membrane protein 140 (GMP 140), and complement pathway regulatoty molecules. The signifìcance of these relationships is currently unknown.
Important questions about ELAM-1 include the nature of the neutrophil ligand for this molecule, whether ELAM-1 is expressed on cell types besides the endothelium and whether stimuli other than cytokines and lipopolysaccharide will induce ELAM-1 expression. Although there is compelling evidente that ELAM-1 bas an important role in the acute infkunmatory response in vivo, this remains to be proven.
CDllKD18
There is evidente for the involvement of molecules other than ELAM-1 in adhesive interactions between neutrophifs and endothelial cells, most notabíy the CDll/CD18 group of leukocyte molecules. This topic was extensively reviewed last year [2] . Briefly, these three related heterodimers all share a common p-chain (CD18), and have unique a-chains (CDlla,b,c) linked non-covalently to the p-chain. CDlla is afso known as lymphocyte function-associated antigen (LFA)-1, CDllb is the type 3 complement receptor, and CDllc is 150/95 or the type 4 complement receptor (Sanchez-Madrid et al., J Exp Med 1983, 158z1785-1803). There is considerable in vitro and in vivo evidente linking these molecules to important adhesive interactions involving neutrophils, monocytes and lymphocytes, as well as evidente from an 'experiment of nature ' [3,4] . The basis of the congenital leukocyte adhesion deficiency syndrome is failure of expression of the CD1 l/CD18 complex; an important characteristic of this syndrome is neutrophil leukocytosis combined with inadequate neutrophil mobilization into sites of bacterial infection, strongly suggesting that neutrophils require adequate expression of CDll/~~$l8 to cross the blood vessel wall.
Experiments using monoclonaL antibodies leave little doubt that the CDll/CD18 complex of the neutrophil has a significant role in adhesion of neutrophils to cytokine-stimulated endothelium, including a recent study of the rekttive signifïcance of the Em.1 and CD1 l/CD18 molecules [ 51. Partial inhibition of in vitre adhesion was caused by antibodies to EIAM-1 or by antibodies to CDlla, CDllb and CD18 after a 4-h expo sure of the endothelium to IL-1, with an addhive effect from combinations of EIAM-1 and CDll/CD18 antibod-ies. The precise interactions, if any, between the neuuophil CDll/CD18 molecules and the endothelial cellasdted EIAM-1 molecule, which lead to intercellular adherente, remain to be identilíed. 
KAM-

Mechanisms of rapidly induced adhesion
It is unlikely that neutrophil adhesion to endothelial cells previously exposed to cytokines represents the sole adhesion mechanism in acute inflammation. 
1972, 222~447-474).
Cytokine-media& adhesion involving transcription, translation, post-translational events, and membrane insertion of the newly synthesized protein( requires a minimum of 0.5 h to become detectable and only becomes prominent after 1-2 h. Two adhesion mechanisms with a rapid onset may be relevant to very early adhesive interactions between neutrophils and endothelial cells.
Approptiately stimulated endothelial cells produce the phospholipid platelet-activating factor (PAF). Endothelial cell-generated PAF or exogenous PAF will induce neutrophil-endothelial adhesion @immerman et dl, J Clin Invest 1985, 76:223%2246). The adhesion is detectable after 1 min, peaks at 5 min, and rapidly wanes thereafter. Thrombin is able to stimulate PAF production in endothelial cells, suggesting that there is a nexus be tween platelets, the coagulation cascade and the inham-, matory response. Interestingly, thrombin-stimulated adhesion does not seem to depend on CD18 molecules to any marked extent [8] .
An adhesion mechanism that depends on complement hxation on the endothelium has recently been dehned [9] . The complement system is a humoral cascade capable of rapid amplihcation and is well known to lx involved in many inflammatory processes. Complement lìxation on endothelial cells leads to neutrophil adhesion within 1 min of complement activation, with adhesion peaking at 20min. The adhesion is maintained as long as a source of complement is available. This adhesion requires no components distal to C3 (i.e C5-49) and is mediated by the complement activation product iC3b, which is lïxed to the endothelial cell and functions as a bridge to the type 3 complement receptor (CDllb/CD18) on the neutrophil. This adhesive mechanism provides a clear role for the involvement of neutrophil CDllb/CDlS binding to a known ligand.
Leukocyte penetration of the vascular wal1
Following attachment, the neutrophil must cross the blood vessel wall and then the subendothelial extracellular matrix to gain access to the extra-vascular compart ment. Recent studies using tissue culture models of the vessel wall have provided some interesting and novel results.
The cytokines TNF and II-1, apart from causing adhesion, also causa neutrophils to migrate through a confluent endothelial cell monolayer [ 101, independently of a chemotactic gradient. The endothelial cell response to the cytokine requires protein synthesis and is due to an activity associated with the apical surface of the endothelium. This migration is not a simple sequelae to adhesion, since adhesion induced by other means (FC interactions) is not associated with migration. The molecular basis of this rnigration is entirely unknown.
A recent study investigated the next event in neutrophil transport into an imlammatoty focus, namely migration through the extracellular matrix (vascular basement membrane) [ 111. This endothelial matrix normally forms an impermeable banier. Once neutrophils have migrated beyond the endothelium, they cross the subendothelial extracellular matrix in a way that is associated with its local physical disruption as defined by increasing permeability of the matrix to colloids, by an as yet unknown mechanism. After the neutrophil has passed through the matrix, the endothelial cell brings about a resealing of the vascular basement membrane by a process requiring protein synthesis that is presumably related to the generation of new basement membrane components.
Leukocyte chemotaxis
Many molecules are capable of causing the migration of phagocytes along a concentration gradient and these have been assumed to be important in attraction to the sites of inllammatory foei. Recently, new families of peptide chemotaxins, which are likely to be of major signiIîcance as physiological mediators of chemotaxis, have been delïned.
The appearance of phagocytes in inllarnmatory lesions is characterized by marked differences in the time course of accumulation of the various cell types (Wilhelm. Zn Pathology edited by Anderson and Kissane. Mosby, 1977, pp 2589).
The molecular basis for this heterogeneity was, until recently, unexplained, but there is now strong evidente for the existente of cell type-speciiíc chemotactic signals. A peptide, neutrophil chemotactic factor (NCF), was purified from activated macrophages (Yoshimura et al, Proc Nat1 Acad Sci USA 1987, 84:92359237) , cloned and sequenced [12] . It is one member of a family of small peptides and is a po tent neutrophil chemotaxin and activator. NCF has target speciiìcity in that it has no effect on macrophages. A macrophage-specifïc (and neutrophil-inactive) chemotaxin has also recently been identiiïed [13] . Although these factors have been characterized from macrophages and cell lines, it is now known that they are also produced by endothelial cells [ 141 as well as other cellular constituents of nomral tissues. It is likely that endothelial cells as well as other cells represent an important source of chemotaxins for the acute Mlamrnatory response.
Mechanisms of tissue injury
Until recent& thinking about the mechanisms by which phagocytes cause tissue damage has evolved in two separate fields, oxidants derived from activity of the plasma membrane oxidase for reduced nicotinamide adenine dinucleotide phosphate (NADPH), and proteinases released from cytoplasmic granules. There is little doubt that phagocyte cell-derived oxidants including superoxide ions, hydrogen peroxide, hypochlorous acid, and the hydroxyl radical are toxic to cells and tissues, resulting in cell damage or death, increases in vascular permeability, fibrosis and amplihcation of the intlammatoty response by mechanisms such as the generation of chemotactic lipids (Warren et al, Patbol Immuncpatbol Res 1987, 6301-315) .
Proteinases derived from phagocytes, while not directly toxic to cells, can bring about hydrolysis of proteins, resulting in tissue disruption.
Recent results have led to an ecumenical view that both oxidants and granule enzymes function in a synergistic marmer to produce the complete toxic capacity of the neutrophil [15] . For example, oxidants are capable of blocking the anti-proteinase activity of blood, allowing proteinase activity to become manifest. Chlorinated oxidan&, (e.g. HOCl) are also capable of converting the latent farms of collagenase (Wiess et al, Science 1985, 227:747-749) and gelatinase (Peppin et al, Proc Nat1 Acad Sci USA 1986, 83:4322-4326) into active enzymes.
Exposure of the basement membrane to oxidants renders it more susceptible to attack by leukocyte proteases (Vissers et al, Bkxhem Bicp&Acta 19s6, .
Thus, the way in which products of activated phagocytic cells cause tissue injury is considerably more complex than previously realized.
Cytokines
It is apparent from the above discussion that cytokines such as TNF and 11-1 have important effects on tissue constituents, such as endothelial cells, and produce multiple reactions responsible for the accumulation of phagocytes in inflammatory lesions. Evidente is accumulating that cytokines have other potent pro-inflammatory effects. cytokines can 'prime' macrophages for enhanced oxy gen radical production [ 161. Their introduction into organs reproduces the acute inflammatory response, with permeability changes and accumulation of neutrophils [ 17,181. Combinations of cytokines have synergistic effects in vivo [ 191. Perhaps the most important and direct evidente for the role of cytokines in the acute inIlammatoty response comes from the discovery that antibodies to TNF will ameliorate the acute inflammatory response caused by deposition of immune complexes in the lung (Warren et al. J Clin Znvest, in press) . Although this does not exclude a role for other mediators, as yet undiscovered, it is compelling evidente that cytokines have an important role in the development of inllammatoty reactions.
~nitial work showed that cytokines are produced by macrophages, but more recently it has emerged that they may be produced by a variety of cell types. Some of these, such as endothelial cells (Libby et al, Am J Patbol 1986, 124:179-185) mast cells [20] and smooth muscle cells
[21] (Wamer et al, JEqD Med 1987 , are present close to sites of acute inflammation, suggesting that there is a broad repertoire of cells that can contribute to the pathogenesis of the acute inllammatoty reaction.
Summary
A major theme in current developments in this field has been the realization that the target tissue, in particular the endothelium, has an active role in initiating and participating in inflammatory reactions and is not a passive target, as was previously thought. Attempts to delineate the mechanisms involved have benefited immeasurably from the application of the modem techniques of molec ular and cellular biology, and will continue to do so. It is axiomatic that a fuller understanding of these mechanisms w%ll result in the development of new strategies designed to black the acute Mlammatory response more speciiïcally and effectively. 
